跳至主要内容
临床试验/NCT01715155
NCT01715155已完成不适用

A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in Clinical Practice in Bulgaria

AstraZeneca2 个研究点 分布在 1 个国家目标入组 171 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
171
试验地点
2
主要终点
Number of progression events on a per patient-year-basis

研究概览

简要总结

The purpose of this study is to evaluate the incidence rate of progression of disease, to describe the diagnostic and clinical management in patients with Metastatic Breast Cancer in the clinical practice in Bulgaria.

详细描述

A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in Clinical Practice in Bulgaria

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • New diagnosis of breast cancer according to ICD-10 with confirmed metastasis
  • Confirmed diagnosis between 1st July 2010 and 30th June
  • Female patient managed for her disease at the same setting where final diagnosis of MBC was performed.

排除标准

  • History of concurrent or other primary malignancies (except curatively resected non-melanoma skin cancer or in situ cervical cancer).

结局指标

主要结局

Number of progression events on a per patient-year-basis

时间窗: Up to 2 years 5 months

次要结局

  • Proportion of patients among study population who have not progressed at 12 and 18 months after they were diagnosed(Up to 2 years 5 months)
  • Median and mean time interval that elapsed between diagnosis and first objective tumor progression (TTP) event and subsequent events(Up to 2 years 5 months)
  • Median and mean time from the date of diagnosis to the date of breast cancer progression or death whichever occurred first(Up to 2 years 5 months)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验